You are in: eMedicine Specialties > Dermatology > DISEASES OF THE ADNEXA Pseudopelade, BrocqArticle Last Updated: Feb 22, 2007AUTHOR AND EDITOR INFORMATIONAuthor: Leonard Sperling, MD, Chair, Professor, Department of Dermatology, Uniformed Services University of the Health Sciences Leonard Sperling is a member of the following medical societies: American Academy of Dermatology Editors: Evan R Farmer, MD, Professor of Dermatology, Johns Hopkins University School of Medicine, Clinical Professor of Pathology, Virginia Commonwealth University School of Medicine; Consulting Staff, Department of Dermatology, Johns Hopkins Hospital, VCU Health Services; Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA; Jeffrey J Miller, MD, Associate Professor, Department of Dermatology, Penn State University, Milton S Hershey Medical Center; Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University; William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System Author and Editor Disclosure Synonyms and related keywords: Brocq pseudopelade, hair loss, cicatricial alopecia, scarring alopecia INTRODUCTIONBackgroundBrocq used the term pseudopelade to describe a peculiar form of scarring alopecia resembling alopecia areata. (Pelade is the French term for alopecia areata.) This clinical entity is not a specific disease but a pattern of scarring alopecia, and the term pseudopelade of Brocq eventually should be abandoned. An additional source of confusion is the modern use of the term pseudopelade to describe a different form of scarring alopecia (ie, central, centrifugal, scarring alopecia [CCSA]). Pseudopelade of Brocq is an end stage or clinical variant of various other forms of scarring alopecia and a diagnosis of exclusion. The same pattern of hair loss can be seen in burnt out (ie, no clinical or histologic evidence of inflammation) discoid lupus erythematosus (DLE), lichen planopilaris (LLP), and other forms of scarring alopecia. If a definitive diagnosis of DLE, LPP, or another condition can be made based on clinical, histologic, or immunofluorescent features, then the term pseudopelade of Brocq cannot be used. A primary form of traditional pseudopelade may exist, but this has yet to be established with certainty. FrequencyInternationalPseudopelade of Brocq is a very uncommon pattern of alopecia. RaceWhites usually are affected more often. SexEither sex can be affected. AgeAdults usually are affected more often, although the condition has been reported in children. CLINICALHistoryThe typical patient is surprised to discover discrete asymptomatic areas of scalp hair loss (Image 1). In many patients, the disease is slowly progressive; ie, new areas of alopecia develop over a period of months to years. However, the condition often worsens in spurts, with periods of activity followed by dormant periods. This is distinctly different from the slow but steady disease progression seen in several other forms of scarring alopecia. Disease progression in pseudopelade eventually ends spontaneously. PhysicalLesions of pseudopelade are randomly distributed, irregularly shaped, and often clustered in patches on the scalp. Cases with exclusive crown or vertex involvement actually may represent examples of burnt-out, central, centrifugal, cicatricial (scarring) alopecia (CCCA). The individual lesion is hypopigmented (porcelain white is the classic description) and slightly depressed (atrophic). Lesions often are shaped irregularly, as opposed to the round or oval patches usually seen in alopecia areata and most cases of CCSA. The classic description of "footprints in the snow" refers to dermal atrophy causing a slight depression below the surrounding normal scalp. In fact, many cases of pseudopelade do not demonstrate atrophy. Usually, only mild erythema and slight perifollicular scaling are present, and, often, no clinical evidence of inflammation is present. In fact, some authors would argue than any inflammation excludes traditional pseudopelade from the clinical differential diagnosis. Typical of many forms of scarring alopecia, a few isolated hairs may remain within an otherwise smooth, shiny, denuded patch. Include the nails and oral mucosa as well as the skin in physical examination to exclude evidence of other forms of scarring alopecia. Pseudopelade of Brocq is a diagnosis of exclusion. CausesPseudopelade of Brocq is felt to be the end stage of several different forms of scarring alopecia, especially lichen planopilaris and chronic cutaneous lupus erythematosus. Therefore, the cause of pseudopelade of Brocq is linked to the etiology of the underlying skin disease. DIFFERENTIALSAplasia Cutis Congenita Lupus Erythematosus, Discoid
| ||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Clobetasol (Temovate) |
|---|---|
| Description | Class I superpotent topical steroid; suppresses mitosis and increases synthesis of proteins that decrease inflammation and cause vasoconstriction. |
| Adult Dose | Apply bid for up to 2 wk; not to exceed 50 g/wk |
| Pediatric Dose | Not established |
| Contraindications | Documented hypersensitivity; viral or fungal skin infections |
| Interactions | None reported |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | May suppress adrenal function in prolonged therapy |
| Drug Name | Fluocinonide (Fluonex, Lidex) |
|---|---|
| Description | High-potency topical corticosteroid that inhibits cell proliferation; is immunosuppressive and anti-inflammatory. |
| Adult Dose | Apply sparingly bid/qid as severity warrants |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity; herpes simplex infection; fungal, viral, or tubercular skin lesions |
| Interactions | None reported |
| Pregnancy | C - Safety for use during pregnancy has not been established. |
| Precautions | May cause adverse systemic effects if used over large areas, denuded areas, on occlusive dressings, or during prolonged treatment periods |
| Media file 1: Irregularly shaped patch of scarring alopecia on the occiput of a middle-aged white woman. This asymptomatic lesion was first discovered by the patient's hairdresser. | |
![]() | View Full Size Image | Media type: Photo |
Article Last Updated: Feb 22, 2007